Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1291-1298
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1291
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1291
Figure 2 Lingguizhugan treatment significantly reduces hepatic steatosis in rats.
A: Liver sections stained with H&E showed decreased fat accumulation in rats administered Lingguizhugan compared to high-fat diet (HFD)-fed rats (scale bar, 100 μm); B: Triglyceride; C: Total cholesterol; D: Low-density lipoprotein cholesterol E: Aspartate aminotransferase/alanine aminotransferase ratio were measured. The data are presented as the mean ± SD (n = 5 for each group) and were analyzed using a spherical test. Statistical comparisons were made compared to the HFD group, aP < 0.05, bP < 0.01. ND: Normal diet; HFD: High-fat diet; LGZG: Lingguizhugan; TC: Total cholesterol; TG: Triglyceride; LDL-C: Low-density lipoprotein cholesterol; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase ratio.
- Citation: Liu XM, Yuan SQ, Ning Y, Nie SJ, Wang XQ, Jia HY, Zheng XL. Therapeutic effects of Lingguizhugan decoction in a rat model of high-fat diet-induced insulin resistance. World J Diabetes 2024; 15(6): 1291-1298
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1291.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1291